Cargando…
Serum and Cerebrospinal Fluid Testing in Optic Neuropathy Patients with Malignant Tumors
PURPOSE: To evaluate the value of serum and cerebrospinal fluid (CSF) testing in optic neuropathy (ON) patients with malignant tumors. METHODS: Fourteen patients clinically diagnosed as ON with malignant tumors but without intracranial or orbital mass in MRI were included in this study. Detailed med...
Autores principales: | Sun, Chuan-bin, Liu, Geng-hao, Xiao, Qing, Zhao, Yi-nv, Ren, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872688/ https://www.ncbi.nlm.nih.gov/pubmed/35222744 http://dx.doi.org/10.1155/2022/7076385 |
Ejemplares similares
-
Infectious Retrovirus Is Inactivated by Serum but Not by Cerebrospinal Fluid or Fluid from Tumor Bed in Patients with Malignant Glioma
por: Shimizu, Keiji, et al.
Publicado: (1995) -
Comparison of complementary diagnostic tests in cerebrospinal fluid and serum for neurocysticercosis
por: Romo, Matthew L., et al.
Publicado: (2018) -
Cerebrospinal fluid and serum interleukins 6 and 8 during the acute and recovery phase in COVID‐19 neuropathy patients
por: Manganotti, Paolo, et al.
Publicado: (2021) -
Detecting changes in the blood flow of the optic disk in patients with nonarteritic anterior ischemic optic neuropathy via optical coherence tomography–angiography
por: Xiao, Qing, et al.
Publicado: (2023) -
Cerebrospinal fluid dynamics along the optic nerve
por: Sheng, Jinqiao, et al.
Publicado: (2022)